← Back to headlines
Summit rises as lead drug from Akeso outperforms Astra’s Imfinzi in late-stage trial
26 Aug, 11:55 — 26 Aug, 11:55
Sources
Showing 1 of 1 sources
Related Stories
FDA Approves Takeda’s Mimrylo for Treatment of Polycythemia Vera
36m ago
Banks Pause Sales of Products Linked to Mark Walter Amid Investigations
1h ago
Rating Agencies Maintain Stable Outlooks for French and Portuguese Sovereign Debt
1h ago
Canada’s Economy Rebounds With 3.3% Growth in Second Quarter
1h ago